Next-generation sequencing in the diagnosis and minimal residual disease assessment of acute myeloid leukemia. Academic Article uri icon

Overview

publication date

  • March 28, 2019

Research

keywords

  • Biomarkers, Tumor
  • High-Throughput Nucleotide Sequencing
  • Leukemia, Myeloid, Acute
  • Neoplasm, Residual
  • Risk Assessment

Identity

PubMed Central ID

  • PMC6518900

Scopus Document Identifier

  • 85065511431

Digital Object Identifier (DOI)

  • 10.3324/haematol.2018.205955

PubMed ID

  • 30923100

Additional Document Info

volume

  • 104

issue

  • 5